Stay updated on the latest business news: from legal implications of private conversations to major acquisitions in biotech and new housing developments to the future of ecommerce. Read more...

Boots has issued a recall of its paracetamol tablets after discovering a labelling error that incorrectly identifies the medication as aspirin. This could potentially mislead customers. Read more...

A recap of insights from the TD Cowen 45th Annual Healthcare Conference, featuring discussions on GSK plc and Agilent Technologies, focusing on their performance and outlook. Read more...

Bank of New York Mellon Corp adjusted its holdings in several companies during the fourth quarter, impacting firms like Sabra Health Care REIT and Zions Bancorporation. Also, analysts update ratings on Xenon, NetApp, and Urban Outfitters. Read more...

This week's health news includes a heartbreaking case of child abuse, alarming wait times for specialists, a professor with terminal cancer, and changes to drug purchasing. Read more...

Today's business news includes GMS Inc.'s Q3 earnings, global drug exports reaching $466.9 billion, and how IRONMAN champion Kelly Barton excels in fintech investing. Also, controversial rental changes in Petržalka are discussed. Read more...

This article summarizes recent analyst ratings for several NASDAQ-listed stocks, including Akero Therapeutics, Alumis, Amneal Pharmaceuticals, BRP Inc., Amplitude, and SoundHound AI. Read more...

Recent news highlights mixed fortunes for Goldman Sachs, including potential layoffs due to over-hiring and analyst downgrades impacting companies like Rocket Pharmaceuticals. Read more...

Recent analyst reports show optimism for several companies, including Apogee Therapeutics, Avadel Pharmaceuticals, and Nvidia, with potential upside for investors. Read more...

A roundup of recent stock market activity, including changes in short interest, earnings expectations, analyst ratings, and institutional investor holdings for several companies. Read more...

Several investment firms, including Illinois Municipal Retirement Fund, New York Life, and Oppenheimer, have adjusted their holdings in companies like NV5 Global, Zillow, and Jazz Pharmaceuticals. Nebius expresses confidence in its AI potential. Read more...

A summary of recent analyst ratings for several companies, including AMN Healthcare, MindMed, Public Storage, Keurig Dr Pepper, Tectonic Therapeutic, and TWFG, Inc. Read more...

A look at the latest earnings estimates and analyst outlook for several companies including Alphabet, Rocket Pharmaceuticals, Pharming Group, Structure Therapeutics, uCloudlink Group, and Longeveron. Read more...

This article summarizes recent market activity, including Whipplewood Advisors' investment in Meta, analyst rating changes for Mattel and Noodles & Company, and Wedbush's updated earnings estimates for Apellis Pharmaceuticals. Read more...

This week's analyst activity includes price target adjustments for Portland General Electric, Neumora Therapeutics, Microchip Technology, ICON Public, and MongoDB. Read more...

Recent market volatility has created potential buying opportunities. This article explores the dip in tech stocks, focusing on AI leaders like Nvidia and other promising companies like Palantir and Devon Energy. Read more...

A roundup of recent analyst ratings and price target adjustments for companies like NetApp, Lexicon Pharmaceuticals, Medpace Holdings, and more. Plus, a look at Nvidia vs. Broadcom in the AI space. Read more...

A look at the potential impact of US tariffs on the Czech Republic, Germany's renewed ambition, and pharmaceutical companies suing the EU over wastewater treatment costs. Read more...

A look at the latest business news, including Rigel Pharmaceuticals' earnings call, Unifi's cost-cutting plans, Analog Devices' buy rating, and Visa/Mastercard investment opportunities. Read more...

This week in health: Fatty liver disease linked to cancer risk in Malaysia, a mechanic customizes wheelchairs, sleep deprivation's impact on immunity, and a court ruling on Ivermectin. Read more...